Results 61 to 70 of about 60,915 (280)

Confirmatory analysis of HBsAg reactive samples from voluntary blood donors

Zhongguo shuxue zazhi
[Objective] To systematically analyze the confirmatory positivity of different combinations of HBsAg screening results in blood testing, providing data to support the optimization of blood donor eligibility management.
ZHANG Qiaolin, WANG Fang, LIU Dong, HAN Fengjiao, LI Liu, ZHENG Xiaochuan, DENG Xuelian, YANG Dongyan   +7 more
doaj   +1 more source

Construction of bicistronic cassette for co-expressing hepatitis B surface antigen and mouse granulocyte-macrophage colony stimulating factor as adjuvant in tobacco plant

Pharmaceutical Biology, 2019
Context: The co-delivery of adjuvant and antigen has shown to be more effective for targeting the immune response than antigen alone. Therefore, designing an efficient bicistronic system is more assuring for production of both elements in the same ...
Sara Mohammadzadeh, Hamideh Ofoghi, Mina Ebrahimi-Rad, Parastoo Ehsani   +3 more
doaj   +1 more source

HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy

Журнал инфектологии, 2014
Presented clinical case describes elimination followed by seroconversion HBsAg / HBsAb patient with HBeAg-negative chronic hepatitis B on antiviral therapy with pegylated interferon α2-a and achieving sustained virological response.
K. V. Zhdanov, D. A. Gusev, K. V. Kozlov, S. S. Zhabrov, A. V. Shekurov, A. V. Nagovitsyn, A. V. Mishin, E. V. Jakovleva   +7 more
doaj   +1 more source

Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 420-434, March 2025.
ABSTRACT Chronic Hepatitis B presents a significant health and socioeconomic burden. The risk of hepatocellular carcinoma remains elevated although treatments are available. Achieving an optimal treatment regimen necessitates a deep comprehension of the dynamic relationship between the virus and its host across disease states.
Clémence Boivin‐Champeaux, Nieves Velez de Mendizabal, Aksana Jones, Scott Balsitis, Stephan Schmidt, Justin S. Feigelman, Francine Johansson Azeredo   +6 more
wiley   +1 more source

Design, Synthesis, Physicochemical and Immunological Characterization of Dendrimer-HBsAg Conjugate

Vaccine Research, 2014
Manufacturing new Hepatitis B virus vaccines, specifically by the use of nanoparticles, is of high global interest. In this paper, a new biocompatible and biodegradable structure of nano-sized hepatitis B virus’ surface antigen (HBsAg) was generated by ...
Mohammad Sadeq Khosravy, Mehdi Shafiee Ardestani, Reza Ahangari Cohan, Delaram Doroud, Safieh Amini, Seyed Bahman Momen, Seyed Mohammad Atyabi, Hossien Heydari, Rohollah Vahabpour   +8 more
doaj  

Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up

, 2016
BACKGROUND & AIMS: Measurements of hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA might help to identify carriers of inactive HBV.
BRUNETTO, MAURIZIA ROSSANA, Hansen, Be, Brouwer, Wp, Martinot Peignoux, M, Cornberg, M, Marcellin, P, Arends, P, Chan, Hl, Good, Practice in using HBsAg in Chronic Hepatitis B. Study Group, Cherubini, B, Liaw, Yf, Thompson, Aj, Janssen, Hl   +12 more
core   +1 more source

Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro [PDF]

, 2017
An impaired HBsAg-secretion can increase HBV oncogenic-properties. Here, we investigate genetic-determinants in HBsAg correlated with HBV-induced hepatocellular carcinoma (HCC), and their impact on HBsAg-secretion and cell ...
Ceccherini-Silberstein, Francesca, Barlattani A., Colledge, D, Continenza, Fabio, Salpini, R, Armenia, D, Spanò, A, Spanò, Alberto, Michienzi A., Ceccherini-Silberstein F., Soppe, S, Locarnini, Stephen, Soppe S., Mirabelli, Carmen, Pasquazzi, Caterina, Verheyen, J, Vecchiet, Jacopo, Salpini R., Colledge, Danny, Missale, Gabriele, Verheyen J., Warner, N, Angelico, M, Fleury, Herve, Sarrecchia, Cesare, Verheyen, Jens, Surdo, Matteo, Angelico, Mario, Vecchiet, J, Andreoni, M, Longo R., Spano A., Di Carlo D., Missale G., Bellocchi M. C., Orecchini, E, Vecchiet J., Trimoulet, P, Svicher V., CECCHERINI SILBERSTEIN, FRANCESCA, Mari, Terenzio, Francioso, Simona, Saccomandi, Patrizia, Longo, Roberta, Francioso, S, Longo, R, Cappiello G., Pollicita M., Michienzi, A, Surdo M., Iapadre, N, Francioso S., Carioti, Luca, Cortese, Mf, Continenza F., Salpini, Romina, Barlattani, Angelo, Carioti L., Mirabelli C., Michienzi, Alessandro, Warner, Nadia, Iapadre N., Ceccherini Silberstein, F, Pollicita, Michela, Spanò, A, Di Carlo, D, Mari T., Romano, Sara, Perno C. F., Ceccherini-Silberstein, F, Warner N., Locarnini, S, Sarrecchia C., Cortese, Maria Francesca, Fleury H., Mari, T, Locarnini S., Saccomandi, P, Svicher, V, Romano, S, Iapadre, Nerio, Romano S., Bertoli A., Cappiello, Giuseppina, Andreoni M., Bellocchi, Mc, Colledge D., Sarrecchia, C, Cappiello, G, Pasquazzi C., Surdo, M, Bellocchi, Maria Concetta, Perno, Cf, Armenia D., Bertoli, A, Pollicita, M, Soppe, Sally, Pasquazzi, C, Armenia, Daniele, Andreoni, Massimo, Mirabelli, C, Barlattani, A, Perno, Carlo Federico, Trimoulet P., Bertoli, Ada, Cortese M. F., Orecchini E., Orecchini, Elisa, Saccomandi P., Continenza, F, Trimoulet, Pascale, Missale, G, Fleury, H, Di Carlo, Domenico, Carioti, L, Svicher, Valentina, Angelico M.   +116 more
core   +1 more source

Applications of chitosan derivatives as adjuvants for nanoparticle‐based vaccines: A comprehensive review

Smart Molecules, EarlyView.
This review highlights how chitosan derivatives enhance nanoparticle‐based vaccines through superior stability, mucoadhesion, and immune modulation. By triggering robust mucosal, humoral, and cellular responses, these biocompatible polymers serve as a transformative platform for next‐generation immunotherapeutics and safe and effective vaccine delivery
Sayantani Dasgupta, Susanta Paul, Swarupananda Mukherjee, Nilanjan Sarkar, Arvind Kumar, Amrita Chakraborty, Anannya Bose, Atanu Hazra, Mainak Chakraborty   +8 more
wiley   +1 more source

Seroprevalence of Hepatitis B Virus Infection Among Patients Attending at Addis Alem Primary Hospital, Bahir Dar, Northwest Ethiopia

International Journal of General Medicine, 2021
Mekuanint Geta,1 Endalew Yizengaw,2 Zegeye Getaneh,3 Tamyalew Getahun4 1Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; 2Departments of ...
Geta M, Yizengaw E, Getaneh Z, Getahun T
doaj  

Plots of Baseline Quantitative HBsAg in those who remained HBsAg positive throughout followup and those who lost HBsAg.

, 2013
Plots of Baseline Quantitative HBsAg in those who remained HBsAg positive throughout followup and those who lost HBsAg.
Anchalee Avihingsanon (340691), Gail V. Matthews (340690), Margaret Littlejohn (340695), Joe Sasadeusz (340689), Kiat Ruxrungtham (247724), Gregory J. Dore (205555), Rachel J. Ali (401104), Scott Bowden (124027), Janaki Amin (157661), Rachel Hammond (259398), Stephen L. Locarnini (401105), Sharon R. Lewin (130160)   +11 more
core   +1 more source